Alemtuzumab (Campath ) ( DrugBank: Alemtuzumab )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
60	再生不良性貧血	1

60. 再生不良性貧血

臨床試験数 : 245 / 薬物数 : 318 - (DrugBank : 86) / 標的遺伝子数 : 44 - 標的パスウェイ数 : 166

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00195624 (ClinicalTrials.gov)	September 15, 2005	16/9/2005	Alemtuzumab to Treat Severe Aplastic Anemia	A Pilot Study of Alemtuzumab (Campath) in Patients With Relapsed or Refractory Severe Aplastic Anemi ...	Severe Aplastic Anemia, Refractory;Severe Aplastic Anemia, Relapse	Biological: Alemtuzumab (Campath );Drug: Cyclosporine	National Heart, Lung, and Blood Institute (NHLBI)	NULL	Completed	2 Years	110 Years	All	47	Phase 2	United States

First Previous1Next Last